Navigation Links
Heterozygote


Heterozygote cells are diploid or polyploid and have different alleles at a locus (position) on homologous chromosomes. When an organism is referred to as a heterozygote, or being heterozygous for a specific gene, it means that the organism carries two different versions of that gene on the two corresponding chromosomes. Heterozygosity refers to both the state of being a heterozygote, but more commonly in population genetics to the fraction of individuals in a population that are heterozygous for that locus.

The effect of heterozygosity depends on the protein product coded for by the gene in question. In some cases a mixture of normal and abnormal proteins is produced. In other cases, the abnormal allele may produce no protein at all. If the proteins are enzymes, the less-functional enzyme molecules usually have no effect and the person is an asymptomatic carrier. If the proteins are structural, such as those that comprise skin or bone matrix, a mixture of normal or abnormal products usually produces abnormal skin or bone, and the resulting abnormality is termed a dominant trait or disease. An abnormal gene that produces no protein may not affect the person at all if the other chromosome has a normal copy of the gene; this would be referred to as a recessive disease.

To describe how a trait inherits (Main article: Mendelian inheritance), the dominant trait is indicated with a capital and the recessive with a lower case character. The colour of Mendel's peas are often indicated as PP for the dominant homozygote pink flower and pp for the recessive homozygote white flower. When these are crossed, the F1 or second generation will be heterozygote for the colour of the flower and this will be indicated with Pp. All F1 plants will flower pink.

Some traits are neither dominant nor recessive but are intermediary: the red carnation crossed with a white carnation will give you heterozygote pink carnations.

See also


'"/>


(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and monoclonal antibody development services, today announced that the company has received ... to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... to announce the next event in a series of TOPIQ webinars, which will ... series of webinars was developed in response to social distancing measures that resulted ...
Breaking Biology News(10 mins):
Other biology definition